Medigene’s PD1-41BB Switch Receptor Enhances TCR-T Cell Activity Towards Solid Tumors

NEXT STORY
BriaCell Announces Presentation of Clinical and Scientific Findings at AACR Annual Meeting
PREV STORY
Preclinical Data from Assembly Biosciences’ Immuno-Oncology Microbiome Program Featured at AACR’s Virtual Annual Meeting II
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

FDA utfärdar IDE-godkännande för användning av Oncology Ventures LiPlaCis DRP för patientselektion i en registreringsgrundande fas 3-studie

author_avatar
NASDAQ Market News

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Arcimoto, Emergent BioSolutions, and Verus International and Encourages Investors to Contact the Firm

author_avatar
NASDAQ Market News

Iterum Therapeutics Announces Revised Results of Rights Offering

author_avatar
NASDAQ Market News